Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellebrite DI (CLBT) Gains from Investment Securities (2020 - 2025)

Historic Gains from Investment Securities for Cellebrite DI (CLBT) over the last 6 years, with Q3 2025 value amounting to $4.7 million.

  • Cellebrite DI's Gains from Investment Securities fell 9342.51% to $4.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.0 million, marking a year-over-year decrease of 8932.15%. This contributed to the annual value of $110.7 million for FY2024, which is 22450.88% up from last year.
  • Per Cellebrite DI's latest filing, its Gains from Investment Securities stood at $4.7 million for Q3 2025, which was down 9342.51% from $1.7 million recorded in Q2 2025.
  • Cellebrite DI's 5-year Gains from Investment Securities high stood at $71.3 million for Q3 2024, and its period low was -$17.1 million during Q1 2022.
  • For the 5-year period, Cellebrite DI's Gains from Investment Securities averaged around $5.2 million, with its median value being $2.1 million (2023).
  • As far as peak fluctuations go, Cellebrite DI's Gains from Investment Securities plummeted by 108201.39% in 2021, and later surged by 336986.37% in 2024.
  • Quarter analysis of 5 years shows Cellebrite DI's Gains from Investment Securities stood at -$15.5 million in 2021, then soared by 107.13% to $1.1 million in 2022, then surged by 785.52% to $9.8 million in 2023, then tumbled by 61.15% to $3.8 million in 2024, then rose by 23.28% to $4.7 million in 2025.
  • Its Gains from Investment Securities stands at $4.7 million for Q3 2025, versus $1.7 million for Q2 2025 and $806000.0 for Q1 2025.